Abstract:Stem cell activity is known to be tightly regulated by both intrinsic and extrinsic pathways but less is known about whether and how stem cells modulate their niche microenvironment. Adult skeletal muscle stem cells (MuSCs) are indispensable for muscle regeneration and also tightly regulated by macrophages (MPs) and fibro-adipogenic progenitors (FAPs) in the niche. Deregulated MuSC/MP/FAP interactions and the ensuing inflammation and fibrosis are hallmarks of dystrophic muscle. Here in this study we demonstrate that intrinsic deletion of transcription factor YY1 in MuSCs exacerbates dystrophic pathologies by altering the cellular composition and heterogeneity of MPs and FAPs. Further analysis reveals that the YY1 loss induces the expression of immune genes in MuSCs, including . Augmented secretion of CCL5 from MuSCs promotes the recruitment of MPs via CCL5/CCR5 mediated crosstalk, which subsequently hinders the apoptosis and clearance of FAPs through elevated TGFβ1 accumulation. Maraviroc mediated pharmacological blockade of the CCL5/CCR5 axis effectively mitigates muscle dystrophy and improves muscle performance. Lastly, we further demonstrate that YY1 represses transcription in MuSCs by directly binding to its enhancer thus facilitating promoter-enhancer looping. Altogether, our study has demonstrated the previously unappreciated role of MuSCs in actively shaping their niche microenvironment through secreting immunomodulatory cytokines, and has also provided novel insight into the therapeutic intervention of muscle dystrophy.

What problem does this paper attempt to address?

The key problem that this paper attempts to solve is: **How do muscle stem cells (MuSCs) regulate the cell composition and interactions in their microenvironment through the YY1 - CCL5 axis, thereby affecting the pathological progression of Duchenne muscular dystrophy (DMD)?** Specifically, the research aims to explore the following issues: 1. **Whether and how muscle stem cells actively regulate their microenvironment**: The traditional view is that stem cells are mainly passively influenced by microenvironmental signals, but this paper attempts to reveal whether muscle stem cells can actively shape their microenvironment by secreting immunomodulatory factors. 2. **The role of the YY1 transcription factor in muscle stem cells**: How does the intrinsic deletion of YY1 change the function of muscle stem cells and their interactions with macrophages (MPs) and fibroblast/adipocyte precursor cells (FAPs), and further affect the pathological features of DMD? 3. **The mechanism of action of the CCL5/CCR5 axis**: The deletion of YY1 leads to the up - regulation of CCL5 expression in muscle stem cells. How does this promote the recruitment of macrophages through the CCL5/CCR5 axis, and ultimately affect the apoptosis and clearance of FAPs, leading to aggravated fibrosis? 4. **Potential therapeutic interventions**: By inhibiting the CCL5/CCR5 axis, can the drug Maraviroc effectively relieve the symptoms of DMD and improve muscle function? ### Research background - **Muscle regeneration and stem cells**: Skeletal muscle has a strong regenerative capacity, which mainly depends on muscle stem cells (MuSCs). These stem cells are in a quiescent state under normal conditions, but will be activated after injury and participate in the repair process. - **Pathological features of DMD**: DMD is a genetic disease caused by mutations in the dystrophin gene, resulting in fragile muscle fibers, repeated injury and regeneration, accompanied by chronic inflammation and fibrosis. - **Intercellular interactions**: The dynamic interactions among muscle stem cells, macrophages and FAPs are crucial for muscle regeneration. Imbalanced interactions can lead to pathological states, such as fibrosis and fat deposition in DMD. ### Research findings - **The impact of YY1 deletion**: The deletion of YY1 in muscle stem cells exacerbates the pathological manifestations in the DMD mouse model (mdx mice), manifested as increased fibrosis, aggravated inflammation and decreased muscle function. - **The role of the CCL5/CCR5 axis**: The deletion of YY1 induces muscle stem cells to secrete CCL5, which recruits more macrophages through the CCL5/CCR5 axis, leading to the accumulation of TGFβ1, inhibiting the apoptosis of FAPs, and further aggravating fibrosis. - **Therapeutic potential**: Using the CCR5 antagonist Maraviroc can effectively relieve the pathological symptoms of DMD mice and improve muscle function. ### Conclusion This study reveals a new mechanism by which muscle stem cells actively regulate their microenvironment by secreting immunomodulatory factors (such as CCL5), and provides new ideas and potential targets for the treatment of DMD.

Skeletal Muscle Stem Cells Modulate Niche Function in Duchenne Muscular Dystrophy through YY1-CCL5 Axis

Inactivating IL34 promotes regenerating muscle stem cell expansion and attenuates Duchenne muscular dystrophy in mouse models

Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity

MuSK-BMP signaling in adult muscle stem cells maintains quiescence and regulates myofiber size

Skeletal Muscle Stem Cells Confer Maturing Macrophages Anti-Inflammatory Properties Through Insulin-Like Growth Factor-2.

Ribonucleotide reductase M2B in the myofibers modulates stem cell fate in skeletal muscle

Muscle-specific microRNA-206 targets multiple components in dystrophic skeletal muscle representing beneficial adaptations

CD90 identifies distinct fractions of muscle stem cells with different modalities of activation and quiescence maintenance

MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injury

Redressing the interactions between stem cells and immune system in tissue regeneration

Apelin stimulation of the vascular skeletal muscle stem cell niche enhances endogenous repair in dystrophic mice

Tcf12 is Required to Sustain Myogenic Genes Synergism with MyoD by Remodelling the Chromatin Landscape

Stem Cell Aging in Skeletal Muscle Regeneration and Disease

Metabolic reprogramming of skeletal muscle by resident macrophages points to CSF1R inhibitors as muscular dystrophy therapeutics

Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration.

METTL3-Mediated m6A Methylation Regulates Muscle Stem Cells and Muscle Regeneration by Notch Signaling Pathway

Interplay between Pitx2 and Pax7 temporally governs specification of extraocular muscle stem cells

CRISPR/Cas9-Based Dystrophin Restoration Reveals a Novel Role for Dystrophin in Bioenergetics and Stress Resistance of Muscle Progenitors

Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion

Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell

Integration of single-cell datasets depicts profiles of macrophages and fibro/adipogenic progenitors in dystrophic muscle